This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

Wayve’s self-learning approach is seen as particularly appealing to automakers because it’s not reliant on specific sensors or HD maps. This means Wayve’s system can work with existing ...

While the results and images of the the shaggy-haired mice were posted online, Colossal did not publish its research in a peer-reviewed journal and it has not been vetted by independent scientists.

Samsung Electronics lost 5.17% and its biotech division dropped 5.71%. Steel giant POSCO Holdings slumped 6.59%. Among shipbuilders, Hanwha Ocean declined 9.81% and HD Hyundai Heavy went down 8.17%.

Moonvalley’s Marey model, built in collaboration with a new AI animation studio called Asteria, offers customization options like fine-grained camera and motion controls, and can generate “HD ...

Wall Street opened the week with volatility as early gains let to a quick reversal. Trump threatened 50% tariffs on China and ended talks, intensifying tensions after Beijing's retaliatory 34% ...

U.S. raises tariffs on key imports, impacting retailers and manufacturers. Apparel, footwear, and home furnishings face steep cost increases. Markets are messy—but the right setups can still ...